We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Stock Moves -0.91%: What You Should Know
Read MoreHide Full Article
Walgreens Boots Alliance (WBA - Free Report) closed the most recent trading day at $52.28, moving -0.91% from the previous trading session. This move was narrower than the S&P 500's daily loss of 1.56%. Meanwhile, the Dow lost 1.19%, and the Nasdaq, a tech-heavy index, lost 1.67%.
Prior to today's trading, shares of the largest U.S. drugstore chain had lost 5.09% over the past month. This has lagged the Retail-Wholesale sector's loss of 3.42% and the S&P 500's loss of 1.22% in that time.
WBA will be looking to display strength as it nears its next earnings release, which is expected to be October 28, 2019. On that day, WBA is projected to report earnings of $1.41 per share, which would represent a year-over-year decline of 4.73%. Our most recent consensus estimate is calling for quarterly revenue of $33.90 billion, up 1.38% from the year-ago period.
Investors should also note any recent changes to analyst estimates for WBA. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.08% lower. WBA is holding a Zacks Rank of #4 (Sell) right now.
Digging into valuation, WBA currently has a Forward P/E ratio of 8.9. Its industry sports an average Forward P/E of 8.9, so we one might conclude that WBA is trading at a no noticeable deviation comparatively.
Investors should also note that WBA has a PEG ratio of 1.34 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. WBA's industry had an average PEG ratio of 1.34 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 177, putting it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Stock Moves -0.91%: What You Should Know
Walgreens Boots Alliance (WBA - Free Report) closed the most recent trading day at $52.28, moving -0.91% from the previous trading session. This move was narrower than the S&P 500's daily loss of 1.56%. Meanwhile, the Dow lost 1.19%, and the Nasdaq, a tech-heavy index, lost 1.67%.
Prior to today's trading, shares of the largest U.S. drugstore chain had lost 5.09% over the past month. This has lagged the Retail-Wholesale sector's loss of 3.42% and the S&P 500's loss of 1.22% in that time.
WBA will be looking to display strength as it nears its next earnings release, which is expected to be October 28, 2019. On that day, WBA is projected to report earnings of $1.41 per share, which would represent a year-over-year decline of 4.73%. Our most recent consensus estimate is calling for quarterly revenue of $33.90 billion, up 1.38% from the year-ago period.
Investors should also note any recent changes to analyst estimates for WBA. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.08% lower. WBA is holding a Zacks Rank of #4 (Sell) right now.
Digging into valuation, WBA currently has a Forward P/E ratio of 8.9. Its industry sports an average Forward P/E of 8.9, so we one might conclude that WBA is trading at a no noticeable deviation comparatively.
Investors should also note that WBA has a PEG ratio of 1.34 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. WBA's industry had an average PEG ratio of 1.34 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 177, putting it in the bottom 31% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.